Renal Cell Cancer
📧 Sign up to get email alerts when something new happens for Renal Cell Cancer.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-01-28EMA Authorised: Oyavas (bevacizumab) — STADA Arzneimittel AG
EMA authorised Oyavas, a bevacizumab biosimilar by STADA, for multiple indications including colorectal, breast, ovarian, fallopian tube, pe…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes
This clinical trial update reports that City of Hope Medical Center's remote telemonitoring study of patient-generated physiological data an…
-
CLINICAL_TRIALS trial_result · 2024-04-12Clinical Trial Update: Study of PF-07263689 in Participants With Selected Advanced Solid Tumors [Phase 1]
Phase 1 trial of PF-07263689 in selected advanced solid tumors was terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2024-03-04Clinical Trial Update: flt3L With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma or Renal Cell Cancer [Phase 2]
Phase 2 trial evaluating flt3L with or without vaccine therapy in patients with metastatic melanoma or renal cell cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-12-06Clinical Trial Update: Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma [Phase 1]
Phase 1 trial assessing trigriluzole in combination with nivolumab and pembrolizumab for various metastatic or unresectable solid tumors and…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-06-07Clinical Trial Update: WIRE - Novel Treatments in Renal Cell Cancer [Phase 2]
Phase 2 clinical trial update for novel treatments in renal cell cancer. Status is currently unknown.
-
CLINICAL_TRIALS trial_result · 2022-06-22Clinical Trial Update: Image Guided Hypofractionated Radiation Therapy, Nelfinavir Mesylate, Pembrolizumab, Nivolumab and Atezolizumab in Treating Patients With Advanced Melanoma, Lung, or Kidney Cancer [Phase 2]
Phase 2 trial investigating image-guided hypofractionated radiation therapy with nelfinavir mesylate and PD-1/PD-L1 inhibitors in advanced m…
-
CLINICAL_TRIALS trial_result · 2022-03-29Clinical Trial Update: T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-DP0401 Positive [Phase 1, Phase 2]
Phase 1/2 trial update on a T cell receptor therapy targeting MAGE-A3 in HLA-DP0401 positive metastatic cancer; study completed with posted …
-
CLINICAL_TRIALS trial_result · 2021-08-09Clinical Trial Update: Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites [NA]
Clinical trial update for Canady Helios cold plasma scalpel at surgical margins and macroscopic tumor sites; status and results data are unc…
-
CLINICAL_TRIALS trial_result · 2021-01-26Clinical Trial Update: Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma [Phase 1, Phase 2]
A Phase 1/2 trial studying vandetanib combined with metformin in patients with hereditary leiomyomatosis-related renal cell carcinoma (HLRCC…
-
CLINICAL_TRIALS trial_result · 2020-08-07Clinical Trial Update: Axitinib Given on an Individualized Schedule for Metastatic Renal Cell Cancer [Phase 2]
Phase 2 clinical trial evaluating individualized axitinib scheduling for metastatic renal cell cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-07-16Clinical Trial Update: A Study Evaluating the Effect of Pembrolizumab (MK-3475) in Participants With Renal Cell Cancer (MK-3475-031) [Phase 1]
Phase 1 trial assessing pembrolizumab in renal cell cancer was terminated with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-06-30Clinical Trial Update: Dose-Finding, Safety and Efficacy Study of RX-0201 Plus Everolimus in Metastatic Renal Cell Cancer [Phase 1, Phase 2]
Phase 1/2 trial of RX-0201 with everolimus in metastatic renal cell cancer has terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2019-09-12Clinical Trial Update: Combination of Cryosurgery and NK Immunotherapy for Advanced Kidney Cancer [Phase 1, Phase 2]
A clinical trial investigating the combination of cryosurgery and NK cell immunotherapy for metastatic renal cell cancer has completed Phase…
-
CLINICAL_TRIALS trial_result · 2019-07-24Clinical Trial Update: Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Stage IV Kidney Cancer [Phase 1, Phase 2]
Phase 1/2 trial investigating low-dose total-body irradiation and fludarabine phosphate followed by donor peripheral blood stem cell transpl…
-
CLINICAL_TRIALS trial_result · 2019-01-03Clinical Trial Update: Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot Be Removed by Surgery [Phase 2]
Phase 2 trial evaluating tivantinib with or without erlotinib in metastatic or locally advanced renal cell carcinoma that cannot be surgical…
-
CLINICAL_TRIALS trial_result · 2019-01-03Clinical Trial Update: 18F-FSPG PET/CT for Cancer Patients on Therapy [Phase 2]
Phase 2 clinical trial update on 18F-FSPG PET/CT for cancer patients undergoing therapy; study status completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-10-16Clinical Trial Update: A Phase 1b Trial in Patients With Renal Cell Cancer [Phase 1]
Phase 1b trial in patients with metastatic renal cell cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-08-16Clinical Trial Update: Sunitinib Malate in Treating Patients With Previously Untreated Metastatic Kidney Cancer [Phase 2]
Phase 2 trial update of sunitinib malate in patients with previously untreated metastatic clear cell renal cell carcinoma (stage IV) has com…
-
CLINICAL_TRIALS trial_result · 2018-06-26Clinical Trial Update: Bevacizumab With or Without TRC105 in Treating Patients With Metastatic Kidney Cancer [Phase 2]
Phase 2 clinical trial evaluating bevacizumab with or without TRC105 in metastatic kidney cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Panobinostat and Everolimus in Treating Patients With Metastatic or Unresectable Renal Cell Cancer That Does Not Respond to Treatment With Sunitinib Malate or Sorafenib Tosylate [Phase 1, Phase 2]
Phase 1/2 trial investigating panobinostat and everolimus in metastatic or unresectable renal cell cancer after failure of sunitinib or sora…
-
CLINICAL_TRIALS trial_result · 2015-11-24Clinical Trial Update: Vorinostat and Isotretinoin in Treating Patients With Advanced Kidney Cancer [Phase 1, Phase 2]
Phase 1/2 trial of vorinostat and isotretinoin in advanced kidney cancer (recurrent/stage III/IV renal cell cancer) has been terminated with…
-
CLINICAL_TRIALS trial_result · 2015-11-06Clinical Trial Update: A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study. [NA]
Continuation study of sunitinib malate for patients who left a prior sunitinib trial; completed with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2009-01-21Clinical Trial Update: Relationship of Ochratoxin A to Upper Urologic Cancers
A completed clinical trial examined the relationship between Ochratoxin A exposure and upper urinary tract cancers, including transitional c…